AC

Alexandra Cantley

Partner at Polaris Partners

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $300,000.00

  • Max Investment:

    $2,000,000.00

  • Target Investment:

    $500,000.00

Skills

High Throughput Screening
Organic synthesis
NMR
Mass Spectrometry
chemical biology
HPLC
Environmental microbiology
Analytical Chemistry
Chemical Biology
Organic Synthesis
Western Blotting

Education

Lists including Alexandra

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

EpiBiologics

Series A

Total Funding: $96M

Auron Therapeutics

Series A

Total Funding: $48M

TRex Bio

Series A

Total Funding: $26M

Work Experience

PP
Polaris Partners

2019

  • Partner

    2021

  • Principal

    2019

Inzen Therapeutics

2017 - 2019

  • Scientist

    2017 - 2019

VP
Vertex Pharmaceuticals

2016 - 2017

  • Vertex Fellow

    2016 - 2017

HU
Harvard University

2011 - 2016

  • Graduate Student

    2011 - 2016

    Clardy Lab Discovery, isolation and synthesis of natural products that mediate symbiotic interactions between microorganisms.

Columbia University

2009 - 2011

  • Research technician

    2009 - 2011

    Stockwell Lab High throughput screening, cancer research